Author: Chi Heem Wong; Kien Wei Siah; Andrew W Lo
Title: Estimating Probabilities of Success of Clinical Trials for Vaccines and Other Anti-Infective Therapeutics Document date: 2020_4_14
ID: fnrm6a79_9
Snippet: 8 Apr 2020 © 2020 by Wong, Siah, and Lo Page 3 of 25 All Rights Reserved When identifying phase transitions, we make the standard assumption that phase 1/2 and phase 2/3 trials are to be considered as phase 2 and phase 3, respectively. We report only drug development programs that have seen at least one trial with a definite outcome......
Document: 8 Apr 2020 © 2020 by Wong, Siah, and Lo Page 3 of 25 All Rights Reserved When identifying phase transitions, we make the standard assumption that phase 1/2 and phase 2/3 trials are to be considered as phase 2 and phase 3, respectively. We report only drug development programs that have seen at least one trial with a definite outcome.
Search related documents:
Co phrase search for related documents- drug development and phase trial: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
- drug development and phase trial phase: 1, 2
- drug development program and phase transition: 1
- drug development program and phase trial: 1
Co phrase search for related documents, hyperlinks ordered by date